title: EXTERNAL VALIDATION OF THE DIAREM SCORE AS REMISSION PREDICTOR OF DIABETES MELLITUS TYPE 2 IN OBESE PATIENTS UNDERGOING ROUX-EN-Y GASTRIC BYPASS.
abstract: BACKGROUND
  DiaRem score consists in preoperative model for predicting remission of type 2 diabetes mellitus in obese patients who underwent gastric bypass.
  
  
  OBJECTIVE
  To evaluate the applicability of DiaRem comparing the scores obtained preoperatively with remission of T2DM after surgery.
  
  
  METHODS
  Preoperative parameters such as age, use of insulin, oral hypoglycemic agents and glycated hemoglobin, were retrospectively evaluated in diabetic patients undergoing gastric bypass during the period between July 2012 to July 2013. Through these data the DiaRem score were applied. The results of fasting blood glucose and glycated hemoglobin were requested prospectively.
  
  
  RESULTS
  Were selected 70 patients; the remission of T2DM after surgery was found in 42 (60%) and no remission in 28 (40%). Checking the final score, it was observed that: from 0 to 2 points, 94.1% of patients remitted completely; between 3 and 7 had remission in 68.9%, of which 42.8% complete; from 8 to 12, 57.1% achieved complete remission; between 13 to 17, 87.5% did not achieve remission and was not seen this complete remission group; between 18 to 22, 88.9% were not remitted.
  
  
  CONCLUSIONS
  The DiaRem score showed appropriate tool to assess remission of T2DM in obese patients who will undergo gastric bypass.
authors.affiliation: Pontifical Catholic University of Paraná, Curitiba, PR, Brazil.
authors.forename: José
authors.initials: J
authors.lastname: Sampaio-Neto
authors.affiliation: Pontifical Catholic University of Paraná, Curitiba, PR, Brazil.
authors.forename: Luís Sérgio
authors.initials: LS
authors.lastname: Nassif
authors.affiliation: Pontifical Catholic University of Paraná, Curitiba, PR, Brazil.
authors.forename: Alcides José
authors.initials: AJ
authors.lastname: Branco-Filho
authors.affiliation: Pontifical Catholic University of Paraná, Curitiba, PR, Brazil.
authors.forename: Luciana Alves
authors.initials: LA
authors.lastname: Bolfarini
authors.affiliation: Pontifical Catholic University of Paraná, Curitiba, PR, Brazil.
authors.forename: Luiara Stefanelo
authors.initials: LS
authors.lastname: Loro
authors.affiliation: Pontifical Catholic University of Paraná, Curitiba, PR, Brazil.
authors.forename: Mayara Prudêncio
authors.initials: MP
authors.lastname: de Souza
authors.affiliation: Pontifical Catholic University of Paraná, Curitiba, PR, Brazil.
authors.forename: Thais
authors.initials: T
authors.lastname: Bianco
mesh_terms: D000328:Adult; D000367:Age Factors; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D005260:Female; D015390:Gastric Bypass; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D008962:Models, Theoretical; D009767:Obesity, Morbid / Q000097:blood / Q000150:complications* / Q000601:surgery*; D011237:Predictive Value of Tests; D011300:Preoperative Care; D011379:Prognosis; D012074:Remission Induction; D012189:Retrospective Studies
chemical_list: D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin